E Fund Management’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $402K | Buy |
14,163
+629
| +5% | +$17.9K | 0.02% | 256 |
|
|
2025
Q1 | $400K | Buy |
13,534
+955
| +8% | +$28.2K | 0.02% | 250 |
|
|
2024
Q4 | $366K | Sell |
12,579
-212
| -2% | -$6.17K | 0.02% | 275 |
|
|
2024
Q3 | $587K | Buy |
12,791
+6,151
| +93% | +$283K | 0.03% | 183 |
|
|
2024
Q2 | $271K | Sell |
6,640
-2,857
| -30% | -$117K | 0.02% | 247 |
|
|
2024
Q1 | $242K | Sell |
9,497
-979
| -9% | -$25K | 0.02% | 308 |
|
|
2023
Q4 | $94.8K | Sell |
10,476
-6,489
| -38% | -$58.7K | 0.01% | 303 |
|
|
2023
Q3 | $108K | Sell |
16,965
-12,499
| -42% | -$79.6K | 0.01% | 282 |
|
|
2023
Q2 | $327K | Buy |
29,464
+11,943
| +68% | +$133K | 0.03% | 208 |
|
|
2023
Q1 | $269K | Buy |
17,521
+5,075
| +41% | +$77.9K | 0.02% | 249 |
|
|
2022
Q4 | $276K | Buy |
+12,446
| New | +$276K | 0.02% | 243 |
|